Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT)

NCT02417974 is registered in ClinicalTrials.gov with Boston Medical Center as lead sponsor.

NCT NCT02417974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02417974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT)
Lead sponsor
Boston Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2015
Completion date
February 4, 2021
Enrollment
24 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease